View in EDS HTML Full Text PDF Full Text

HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancer.

Saved in:

Bibliographic Details
Title:	HDAC inhibitors modulate Hippo pathway signaling in hormone positive breast cancer.
Authors:	Lin, Ting-I^1,2 (AUTHOR), Tseng, Yi-Ru^1,2 (AUTHOR), Dong, Min-Jyun^1,2 (AUTHOR), Lin, Chih-Yi^1,2 (AUTHOR), Chung, Wei-Ting^1,2 (AUTHOR), Liu, Chun-Yu^1,3,4,5 (AUTHOR), Tsai, Yi-Fang^3,4,6 (AUTHOR), Huang, Chi-Cheng^3,4,6 (AUTHOR), Tseng, Ling-Ming^3,4,6 (AUTHOR), Chao, Ta-Chung^1,3,4,5 (AUTHOR), Lai, Jiun-I^1,2,3,4,5 (AUTHOR) jilai@nycu.edu.tw
Source:	Clinical Epigenetics. 2/26/2025, Vol. 17 Issue 1, p1-14. 14p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Description
ISSN:	18687075
DOI:	10.1186/s13148-025-01834-y